Solomon Park Research Labs

Solomon Park Research Laboratories is a long-established, privately-held US company that operates as a critical supplier to the global diagnostics and biotechnology industry. Its core business is the collection, processing, and distribution of meticulously characterized human serum and plasma products, which serve as essential quality control and calibration materials for laboratory testing. The company leverages a specialized blood draw process (CLSI C37-A) developed with the CDC to ensure product commutability and accuracy. With over 2,000 customers in 10 countries, Solomon Park has built a reputation as a trusted partner for labs requiring standardized biological materials to ensure testing accuracy and compliance.

Specialized manufacturing platform using CLSI C37-A procedure for producing commutable human serum and plasma products. Includes CQM Cloud software for laboratory quality control data tracking.

Operates in a niche segment competing with other specialty biological material suppliers and the in-house capabilities of large IVD manufacturers. Differentiation is based on product commutability (via the C37-A process), donor characterization, and the prestigious CDC Lipid Standardization Program partnership.